Home › Funds › 5AM Venture Management, LLC › ZNTL

5AM Venture Management, LLC position in ZNTL

ZENTALIS PHARMACEUTICALS INC · Health Care

5AM Venture Management, LLC reported holding 3,947,913 shares of ZNTL (ZENTALIS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$19.1M, representing 6.65% of its reported portfolio and ranking #8 among its reported holdings. 5AM Venture Management, LLC has disclosed ZNTL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.95M sh
Reported value held$19.15M
Portfolio Weight6.65%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How 5AM Venture Management, LLC's ZNTL position evolved

5AM Venture Management, LLC first disclosed a stake in ZNTL in Q3 2023 at 490,000 shares (US$9.8M). The position peaked in Q2 2026 at 3,947,913 shares, worth US$19.1M. Across 12 filings, 5AM Venture Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 3,947,913 shares valued at US$19.1M. Notable position changes include a 706% increase in Q4 2025 (shares rose 73% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 490.00K $9.83M New
Q4 2023 490.00K $7.42M Hold
Q1 2024 490.00K $7.72M Hold
Q2 2024 490.00K $2.00M Hold
Q3 2024 490.00K $1.80M Hold
Q4 2024 490.00K $1.48M Hold
Q1 2025 490.00K $779.10K Hold
Q2 2025 490.00K $568.40K Hold
Q3 2025 490.00K $739.90K Hold
Q4 2025 3.95M $5.33M Add
Q1 2026 3.95M $9.24M Hold
Q2 2026 3.95M $19.15M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZNTL and 13F data

ZNTL (ZENTALIS PHARMACEUTICALS INC) is a Health Care company. 29 other funds we track also report a position in ZNTL — the largest reported positions include Opaleye Management Inc. (US$6.9M), Decheng Capital LLC (US$6.4M), Ishara Investments LP (US$5.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZNTL

All ZNTL fund holders →

FAQ

How long has 5AM Venture Management, LLC held ZNTL?

5AM Venture Management, LLC has disclosed ZNTL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is 5AM Venture Management, LLC's current position in ZNTL?

As of Q2 2026, 5AM Venture Management, LLC holds 3.95M shares of ZNTL (ZENTALIS PHARMACEUTICALS INC), valued at $19.15M, representing 6.65% of its reported portfolio and ranking #8.

Has 5AM Venture Management, LLC been buying or selling ZNTL?

In the latest 13F filing (Q2 2026), 5AM Venture Management, LLC held unchanged its position in ZNTL. The position peaked in Q2 2026 at 3.95M shares.

Which other funds hold ZNTL?

Other major institutional holders of ZNTL include Opaleye Management Inc., Decheng Capital LLC, Ishara Investments LP, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.